Zai Lab Limited (ZLAB)
NASDAQ: ZLAB · IEX Real-Time Price · USD
-0.53 (-2.66%)
At close: May 17, 2024, 4:00 PM
+0.60 (3.09%)
Pre-market: May 20, 2024, 7:33 AM EDT

Zai Lab Revenue

Zai Lab had revenue of $291.07M in the twelve months ending March 31, 2024, with 25.94% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $87.15M with 38.78% year-over-year growth. In the year 2023, Zai Lab had annual revenue of $266.72M with 24.03% growth.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
1.92B USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 2023266.72M51.68M24.03%
Dec 31, 2022215.04M70.73M49.01%
Dec 31, 2021144.31M95.35M194.77%
Dec 31, 202048.96M35.97M277.04%
Dec 31, 201912.99M12.86M9,965.89%
Dec 31, 2018129.00K--
Dec 31, 20170--
Dec 31, 20160--
Dec 31, 20150--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Novavax 996.61M
Warby Parker 697.80M
NeoGenomics 610.66M
Catalyst Pharmaceuticals 411.35M
Ardelyx 159.11M
Agios Pharmaceuticals 29.40M
Keros Therapeutics 234.00K
Revenue Rankings